Durga Buchi Raju Barre

Title: Innovations of Durga Buchi Raju Barre

Introduction

Durga Buchi Raju Barre is a notable inventor based in East Godavari, India. He has made significant contributions to the field of pharmaceutical compounds, holding a total of three patents. His work focuses on developing innovative compounds that have the potential to treat various inflammatory and autoimmune diseases.

Latest Patents

One of his latest patents involves substituted bicyclic heteroaryl compounds. This patent discloses compounds of Formula (I) N-oxides, or salts thereof, wherein X, Y, A, G, R, and R are defined. The patent also outlines methods for using these compounds as inhibitors of signaling through Toll-like receptors 7, 8, or 9. These compounds are particularly useful in treating inflammatory and autoimmune diseases. Another significant patent by Barre pertains to 6-azaindole compounds. Similar to the previous patent, it discloses compounds of Formula (I) N-oxides, or salts thereof, with specific definitions for A, G, R, R, and n. This patent also details methods for using these compounds as inhibitors of signaling through Toll-like receptors 7, 8, or 9, emphasizing their utility in treating inflammatory and autoimmune diseases.

Career Highlights

Durga Buchi Raju Barre is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to contribute to the development of innovative therapies that address critical health challenges.

Collaborations

Some of his notable coworkers include Alaric J Dyckman and Sreekantha Ratna Kumar. Their collaboration has likely fostered an environment of innovation and creativity, enhancing the research and development efforts at Bristol-Myers Squibb.

Conclusion

Durga Buchi Raju Barre's contributions to the field of pharmaceutical innovations are commendable. His patents reflect a commitment to advancing medical science and improving patient outcomes. His work continues to inspire future innovations in the treatment of inflammatory and autoimmune diseases.